Three Pew Scholars Named AAAS Fellows

The American Association for the Advancement of Science, or AAAS, on Nov. 25 named 338 new fellows, including Pew biomedical scholars James Bliska (1994), M. Bishr Omary (1989), and Richard Padgett (1986). AAAS fellows are selected based on their demonstrated efforts to advance science or its applications.

James Bliska, a professor of molecular genetics and microbiology at Stony Brook University, has been elected as a fellow of AAAS' Section on Medical Sciences for his studies of disease-causing bacteria.

M. Bishr Omary, a professor of molecular and integrative physiology at the University of Michigan, has also been elected as an AAAS fellow in Medical Sciences. Omary's work focuses on gastroenterology and cell biology.

Richard A. Padgett, a staff member of the Lerner Research Institute at the Cleveland Clinic, has been recognized as a fellow of AAAS' Section on Biological Sciences for his research into gene regulation.

Find out more.
James Bliska,
1994 Pew biomedical scholar 
Find out more.
M. Bishr Omary,
1989 Pew biomedical scholar
  Find out more.
Richard A. Padgett,
1986 Pew biomedical scholar


View the press release and full list of honorees from AAAS here: http://www.aaas.org/news/releases/2013/1125_fellows.shtml  

Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.